University of Chicago, Duchossois Center for Advanced Medicine (DCAM) — Chicago, Illinois

University of Chicago, Duchossois Center for Advanced Medicine (DCAM) is a clinical research site located in Chicago, Illinois, United States 60637.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

University of Chicago, Duchossois Center for Advanced Medicine (DCAM) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS).

Sponsors: Institut de Recherches Internationales Servier.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Chicago, Duchossois Center for Advanced Medicine (DCAM)?

University of Chicago, Duchossois Center for Advanced Medicine (DCAM) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Chicago, Duchossois Center for Advanced Medicine (DCAM) conducted?

University of Chicago, Duchossois Center for Advanced Medicine (DCAM) has 1 clinical trials on record, with 1 currently active. Their work covers Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS).

Is University of Chicago, Duchossois Center for Advanced Medicine (DCAM) accredited by Crixeo Health?

University of Chicago, Duchossois Center for Advanced Medicine (DCAM) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Chicago, Duchossois Center for Advanced Medicine (DCAM)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.